Company news

Medical Developments International Limited news in 2026

Medical Developments International Limited's news releases, calls and decks from 2026, newest first.

View company

Change in substantial holding

October 29, 2026

Appendix 4C and Quarterly Activity Report -30 September 2026

October 14, 2026

CEO Transition

October 14, 2026

Corporate Governance Statement 2026

October 8, 2026

Notice of Annual General Meeting 2026

October 8, 2026

Annual Report 2026

October 8, 2026

Appendix 4G 2026

October 8, 2026

Notification of cessation of securities - MVP

September 29, 2026

Date of AGM and Closing Date for Director Nominations

September 17, 2026

MVP Announces FY26 Full Year Results

August 19, 2026

FY26 Full year Results Investor Presentation

August 19, 2026

FY26 Full Year Results

August 19, 2026

Change in substantial holding

August 17, 2026

FY26 Full Year Results Announcement Details

August 12, 2026

Appendix 4C and Quarterly Activity Report 30 June 2026

July 23, 2026

Appendix 4C and Quarterly Activity Report 31 March 2026

April 23, 2026

FY26 Half Year Presentation

February 18, 2026

FY26 Half Year Announcement

February 18, 2026

FY26 Half Year Report (including Appendix 4D)

February 18, 2026

Appendix 4C and Quarterly Activity Report 31 December 2025

January 29, 2026

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

January 7, 2026

Calls in 2026

Decks in 2026